1. Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats;Nabata;Arch. Int. Pharmacodyn. Ther.,1985
2. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: Antagonism at α1-adrenergic and 5-HT2 receptors;Aono;Arch. Int. Pharmacodyn. Ther.,1985
3. Potent α-adrenoceptor blocking action of SGB-1534, a new quinazoline antihypertensive agent in vitro experiments;Shibata;Gen. Pharmacol.,1986
4. Further evaluation of the selectivity of a novel antihypertensive agent, SGB-1 534, for peripheral α1-adrenoceptors in the spinally anesthetized dog;Imagawa;Eur. J. Pharmacol.,1986
5. Effect of SGB-1534, an antihypertensive agent, on 3H-prazosin and 3H-paraaminoclonidine binding to α1- and α2-adrenoceptors in dog brain and aorta;Nagatomo;Folia Pharmacol. Japon.,1986